专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

81. 发明申请

US20170036840A1 EVACUATED BOTTLE SYSTEM 有权
标题翻译：脱脂瓶系统
公开(公告)号：US20170036840A1
公开(公告)日：2017-02-09
申请号：US15333452
申请日：2016-10-25
申请人： CORNERSTONE CM, INC.
发明人： Michael G. Marantis , JOSHUA W. HUBBARD , JONATHAN P. RICHARDS , RICHARD A. PONTON
IPC分类号： B65D81/20 , A61M1/00 , B65B31/00 , B65B55/10 , B67C11/02 , A61J1/14
CPC分类号： B65D81/2038 , A61J1/14 , A61J1/1406 , A61J1/1412 , A61J1/1418 , A61M1/0001 , A61M1/0003 , A61M1/0011 , B65B31/00 , B65B55/10 , B67C11/02 , B67C2011/20
摘要： An evacuated bottle system including a bottle defining a hollow interior, the bottle having a neck defining an opening that provides fluid communication with the interior; a cap assembly including a funnel having a first portion and a second portion, where the second portion extends radially outward from the first portion to form a floor on an interior thereof and a shoulder on an exterior thereof, the first portion defining a first bore and the second portion defining a second bore fluidly connected to the first bore; a self serum stopper having a self sealing membrane that extends radially outward to overlie at least a portion of the floor of the funnel; and a cap having a cap wall sized to fit over the funnel and a cover portion extending radially inward from the cap wall.
摘要翻译：一种抽真空的瓶子系统，其包括限定中空内部的瓶子，该瓶子具有颈部，该颈部限定了与内部流体连通的开口; 帽组件，其包括具有第一部分和第二部分的漏斗，其中所述第二部分从所述第一部分径向向外延伸以在其内部形成底板，并且在其外部形成肩部，所述第一部分限定第一孔，所述第二部分限定流体连接到所述第一孔的第二孔; 自清血塞具有自密封膜，其径向向外延伸以覆盖在漏斗的底部的至少一部分上; 以及盖，其具有尺寸适于装配在漏斗上的盖壁和从盖壁径向向内延伸的盖部分。

82. 发明申请

US20160325322A1 PHARMACEUTICAL WASTE DISPOSAL ASSEMBLY 审中-公开
标题翻译：药物废物处理装置
公开(公告)号：US20160325322A1
公开(公告)日：2016-11-10
申请号：US15213950
申请日：2016-07-19
申请人： CACTUS, LLC
发明人： David A. Maness
IPC分类号： B09B3/00 , A61J1/00
CPC分类号： B09B3/0075 , A61B50/20 , A61B50/36 , A61B50/37 , A61B50/39 , A61B90/98 , A61B2017/00132 , A61B2050/0054 , A61J1/00 , A61J1/14 , B65D81/264 , G06F19/00
摘要： A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste includes a receiver body (19) and a first reaction agent (287). The receiver body (19) is configured to receive the pharmaceutical waste. The receiver body (19) includes a body interior wall (921A) that defines a body interior (921B). The first reaction agent (287) is positioned within the body interior (921B) so that the first reaction agent (287) contacts the body interior wall (921A) prior to receiving the pharmaceutical waste. The first reaction agent (287) chemically reacts with the pharmaceutical waste so that the pharmaceutical waste is rendered unrecoverable. The first reaction agent (287) can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent (287) can include activated charcoal.
摘要翻译：用于处置原料药废物的药物废物处理组件（10）包括接收器主体（19）和第一反应剂（287）。接收器主体（19）被配置为接收药物废物。接收器主体（19）包括限定主体内部（921B）的主体内壁（921A）。第一反应剂（287）位于主体内部（921B）内，使得第一反应剂（287）在接收药物废物之前与本体内壁（921A）接触。第一反应剂（287）与药物废物发生化学反应，使得药物废物不可恢复。第一反应剂（287）可以包括变性剂和威慑物中的至少一种。另外，第一反应剂（287）可以包括活性炭。

83. 发明授权

US09463137B2 Methods, packaging and apparatus for collection of biological samples 有权
标题翻译：方法，包装和收集生物样品的仪器
公开(公告)号：US09463137B2
公开(公告)日：2016-10-11
申请号：US14397447
申请日：2013-03-15
申请人： CYTOCORE, INC.
发明人： Richard A. Domanik
IPC分类号： B65D77/06 , A61J1/14 , A61B10/00
CPC分类号： A61J1/14 , A61B10/0045 , A61B10/0096 , A61B2010/0074 , B65D77/06
摘要： Methods, apparatus and compositions are disclosed for collection and transport of biological samples for testing and/or evaluation by a clinical laboratory. In particular, the disclosure relates to the self-collection of such samples by subjects providing the samples. Self-collection is necessary in some situations e.g. where a subject's religion prohibits being touched by a non-family member and subjects at great distance from medical facilities.
摘要翻译：公开了用于收集和运输用于临床实验室进行测试和/或评估的生物样品的方法，装置和组合物。特别地，本公开涉及通过提供样品的受试者自己收集这些样品。在某些情况下，需要进行自我收集，例如受试者的宗教禁止被非家庭成员和远离医疗设施的受试者感动。

84. 发明授权

US09421350B2 Wound management device 有权
标题翻译：伤口管理装置
公开(公告)号：US09421350B2
公开(公告)日：2016-08-23
申请号：US13813230
申请日：2011-07-29
申请人： Neil Wiltshire , Eric Davison
发明人： Neil Wiltshire , Eric Davison
IPC分类号： A61M35/00 , A61F13/02 , A61J1/10 , A61J1/14 , A61F13/00 , A61M1/00 , A61M27/00
CPC分类号： A61M35/00 , A61F13/00068 , A61F13/02 , A61F13/0216 , A61F2013/00412 , A61J1/10 , A61J1/14 , A61J1/1475 , A61M1/0023 , A61M1/0058 , A61M1/0084 , A61M1/0086 , A61M1/0088 , A61M27/00
摘要： A wound management device comprising at least one wall element of flexible sheet material, the device being securable to skin around a wound site to define a space wherein the wound is accessible; and a connector element held to the at least one wall element and affording at least one passage for external communication with the space; wherein the connector element includes at least one formation through which the or a passage extends, for engagement by a member for fluid supply to or removal from the space.
摘要翻译：一种伤口管理装置，其包括至少一个柔性片材的壁元件，所述装置可固定在伤口部位周围的皮肤以限定伤口可接近的空间; 以及连接器元件，其保持在所述至少一个壁元件上并且提供至少一个通道，用于与所述空间的外部连通; 其中所述连接器元件包括至少一个构件，所述至少一个构件或所述通道延伸穿过所述构件，用于通过构件进行接合以供流体供应或从所述空间移除。

85. 发明授权

US09414989B2 Pharmaceutical product container with permanent locking mechanism 有权
标题翻译：具有永久锁定机构的药品容器
公开(公告)号：US09414989B2
公开(公告)日：2016-08-16
申请号：US14488048
申请日：2014-09-16
申请人： Mallinckrodt LLC
发明人： Robert J. Ziemba , Vernon D. Ortenzi
IPC分类号： A61J1/14 , E05B73/00 , B65D45/00 , A61J1/03 , B65D55/12
CPC分类号： A61J1/1437 , A61J1/03 , A61J1/14 , B65D45/00 , B65D55/12 , B65D2255/20 , E05B73/0023
摘要： Various embodiments of pharmaceutical product containers are disclosed. Each pharmaceutical product container includes a cap, a container body, and a locking mechanism. The locking mechanism is disposable from a locked state to an unlocked state at least when the cap is in a closed position relative to the container body (e.g., to define an enclosed space for pharmaceutical product). Once in the locked state and with the cap being in a closed position, the locking mechanism is unable to return to its unlocked state. Pharmaceutical product enclosed within the container with the locking mechanism being in its locked state may then be disposed of in any appropriate manner (e.g., discarded in the trash).
摘要翻译：公开了药品容器的各种实施方案。每个药品容器包括帽，容器主体和锁定机构。至少当盖子相对于容器主体处于关闭位置（例如为了制定用于制药产品的封闭空间）时，锁定机构可以从锁定状态一次性到解锁状态。一旦处于锁定状态并且盖处于关闭位置，锁定机构就不能返回其解锁状态。封闭在具有锁定机构处于其锁定状态的容器内的药品可以以任何适当的方式（例如，丢弃在垃圾中）进行处置。

86. 发明申请

US20160220444A1 AMPOULE FOR MEDICAL LIQUID AND METHOD FOR PRODUCING AN AMPOULE 审中-公开
标题翻译：医药用液体及其制备方法
公开(公告)号：US20160220444A1
公开(公告)日：2016-08-04
申请号：US15021006
申请日：2014-09-12
申请人： FRESENIUS KABI DEUTSCHLAND GMBH
发明人： Torsten Brandenburger , Ismael Rahimy , Christian Ebert
IPC分类号： A61J1/06 , B29C49/00 , B29C49/46 , A61J1/20 , A61J1/18
CPC分类号： A61J1/065 , A61J1/067 , A61J1/14 , A61J1/18 , A61J2205/30 , B29B2911/1442 , B29C49/0073 , B29C49/46 , B29C2049/4664 , B65D1/0238 , B65D1/095
摘要： An ampoule for a medical liquid comprises an ampoule body for accommodating a medical liquid and a connection part for connecting a removal device to the ampoule, which connection part extends in a longitudinal extension direction and adjoins the ampoule body. The connection part and the ampoule body are formed as one piece and the connection part has a threaded segment having at least two thread turns arranged thereon, which are axially offset from each other in the longitudinal extension direction. The ampoule enables simple attachment of a removal device, creates a tight transition between a connection part and the removal device, is simple and economical to produce, and can provide a defined attachment state for the removal device on the ampoule.
摘要翻译：用于医用液体的安瓿包括用于容纳医用液体的安瓿主体和用于将移除装置连接到安瓿的连接部，所述连接部沿纵向延伸方向延伸并邻接安瓿主体。连接部和安瓿主体形成为一体，连接部具有螺纹段，该螺纹段具有沿纵向延伸方向彼此轴向偏移的至少两个螺纹线。安瓿使得能够简单地附接移除装置，在连接部件和移除装置之间形成紧密的过渡，制造简单且经济，并且可以为安瓿上的去除装置提供限定的附接状态。

87. 发明申请

US20150354894A1 Lyophilization 有权
标题翻译：冻干
公开(公告)号：US20150354894A1
公开(公告)日：2015-12-10
申请号：US14734832
申请日：2015-06-09
申请人： TERUMO BCT, INC.
发明人： Frank CORBIN, III , Dennis J. HLAVINKA , Rajesh PARETA , Mark E. HILLAM
IPC分类号： F26B5/06 , A61L2/08 , A61J1/14
CPC分类号： F26B5/06 , A01N1/0252 , A01N1/0263 , A01N1/0284 , A01N1/0289 , A61J1/10 , A61J1/14 , A61J1/1468 , A61J1/1475 , A61L2/084 , A61L2/085 , A61L2/088 , A61L2/10 , A61L2202/22 , A61M1/0209 , A61M1/0272 , A61M1/0286 , A61M2202/0415
摘要： Embodiments of methods, systems, and apparatuses for lyophilizing, storing, and transfusing materials are described. In embodiments, the materials may include whole blood or a component of whole blood such as plasma.
摘要翻译：描述用于冻干，储存和输送材料的方法，系统和装置的实施例。在实施方案中，所述材料可以包括全血或全血的成分，例如血浆。

88. 发明授权

US09101392B2 Information reader of injection container 有权
标题翻译：注射容器的信息阅读器
公开(公告)号：US09101392B2
公开(公告)日：2015-08-11
申请号：US13673399
申请日：2012-11-09
申请人： Ookuma Electronic Co., Ltd.
发明人： Keiji Okuma
IPC分类号： A61J1/14 , A61B19/00 , B65B3/00 , F16M13/02 , A61J1/00 , B65C3/10 , A61M5/00
CPC分类号： A61B19/44 , A61B90/90 , A61B90/96 , A61J1/00 , A61J1/14 , A61J2205/10 , A61M5/00 , A61M5/3129 , A61M2205/6063 , A61M2205/6072 , A61M2207/10 , B65B3/003 , B65B3/006 , B65C3/10 , F16M13/022 , G06K2209/01
摘要： An information reader of an injection container that includes a container clamping mechanism clamping side portions of the injection container, the container clamping mechanism includes a pair of first clamping bodies arranged on one side of the side portions of the injection container, and a second clamping body capable of entering between the pair of the first clamping bodies. Each of the pair of the first clamping bodies includes a first clamping unit having a first recess in an approximate doglegged shape, and a first arm portion projecting approximately horizontally from a lower end portion of the first clamping unit. The second clamping body includes a second clamping unit having a second recess in an approximately reverse doglegged shape formed to face against the first recess, and a second arm portion projecting approximately horizontally from a lower end portion of the second clamping unit.
摘要翻译：一种注射容器的信息读取器，其包括夹持注射容器的侧部的容器夹紧机构，所述容器夹持机构包括布置在注射容器的侧部的一侧上的一对第一夹持体和第二夹持体能够进入一对第一夹持体之间。所述一对第一夹持体中的每一个包括第一夹持单元，该第一夹持单元具有大致弯曲形状的第一凹部和从第一夹持单元的下端部大致水平地突出的第一臂部。第二夹持体包括第二夹持单元，该第二夹持单元具有形成为朝向第一凹部形成的近似反方向形状的第二凹部，以及从第二夹紧单元的下端部大致水平地突出的第二臂部。

89. 发明申请

US20150098969A1 ALTERNARIA PEPTIDES 审中-公开
公开(公告)号：US20150098969A1
公开(公告)日：2015-04-09
申请号：US14403464
申请日：2013-05-30
申请人： Circassia Limited
发明人： Roderick Peter Hafner , Paul Laidler , Pascal Hickey , Mark Larche
IPC分类号： C07K7/08 , A61J1/14 , G01N33/50
CPC分类号： C07K7/08 , A61J1/14 , C07K14/37 , G01N33/5094
摘要： Pharmaceutical formulations, which may be used for preventing or treating allergy to moulds of the Alternaria and/or Cladosporium genus, comprising a pharmaceutically acceptable carrier or diluent and a polypeptide or a pharmaceutically acceptable salt thereof selected from at least three of: (a) a polypeptide comprising the amino acid sequence of WSWKIGPAIATGNT (Alt28; SEQ ID NO: 101) or a T cell epitope-containing variant sequence derived from said amino acid sequence, or a said salt thereof; (b) a polypeptide comprising the amino acid sequence of KYRRVVRAGVKVAQTAR (Alt34A; SEQ ID NO: 107) or a T cell epi tope-containing variant sequence derived from said amino acid sequence, or a said salt thereof; (c) a polypeptide comprising the amino acid sequence of KYAGVFVSTGTLGGG (SEQ ID NO: 112) or a T cell epitope-containing variant sequence derived from said amino acid sequence, or a said salt thereof; (d) a polypeptide comprising the amino acid sequence of AEVYQKLKALAKKTYGQ (Alt13A; SEQ ID NO: 83) or a T cell epitope-containing variant sequence derived from said amino acid sequence, or a said salt thereof; (e) a polypeptide comprising the amino acid sequence of SLGFNIKATNGGTLD (Alt01A; SEQ ID NO: 60) or a T cell epi tope-containing variant sequence derived from said amino acid sequence, or a said salt thereof; (f) a polypeptide comprising the amino acid sequence of SAKRMKVAFKLDIEK (Alt06; SEQ ID NO: 72) or a T cell epitope-containing variant sequence derived from said amino acid sequence, or a said salt thereof; (g) a polypeptide comprising the amino acid sequence of DITYVATATLPNYCR (SEQ ID NO: 111) or a T cell epitope-containing variant sequence derived from said amino acid sequence, or a said salt thereof; and (h) a polypeptide comprising the amino acid sequence of GWGVMVSHRSGET (Alt14; SEQ ID NO: 84) or a T cell epi tope-containing variant sequence derived from said amino acid sequence, or a said salt thereof; wherein a T cell epitope-containing variant sequence of a said amino acid sequence is said amino acid sequence having up to seven amino acid modifications, each of which is independently a deletion, substitution or insertion, and each polypeptide is up to 30 amino acids in length.

90. 发明申请

US20150098950A1 LIQUID FORMULATIONS OF TUMOR NECROSIS FACTOR-BINDING PROTEINS 审中-公开
标题翻译：肿瘤坏死因子结合蛋白的液体制剂
公开(公告)号：US20150098950A1
公开(公告)日：2015-04-09
申请号：US14570244
申请日：2014-12-15
申请人： ARES TRADING S.A.
发明人： Fabrizio Samaritani , Alessandra Del Rio , Rita Agostinetto
IPC分类号： C07K16/24
CPC分类号： A61K38/1793 , A61J1/14 , A61K9/08 , A61K47/02 , A61K47/12 , A61K47/26 , C07K16/241 , C07K2317/94
摘要： The invention relates to a stable, pharmaceutically acceptable, aqueous formulation of TNF-binding protein, comprising a TNF-binding protein, a buffer and an isotonicity agent.
摘要翻译：本发明涉及稳定的药学上可接受的TNF结合蛋白质的水性制剂，其包含TNF结合蛋白，缓冲液和等渗剂。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式